{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:50:53Z","timestamp":1775818253481,"version":"3.50.1"},"reference-count":39,"publisher":"American Association for Cancer Research (AACR)","issue":"9","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Low antigen expression and an absence of coimmunostimulatory signals may be partly responsible for the low immunogenicity of many tumors. It may be possible to overcome this situation by defining a combination of adjuvants and antigens that can activate a high-avidity antitumor response. Using the poorly immunogenic B16-OVA melanoma cells as tumor model, we tested different combinations of adjuvants and antigens to treat established tumors. In the absence of exogenous antigens, repeated administration of the TLR7 ligand Imiquimod together with anti-CD40 agonistic antibodies activated only innate immunity, which was insufficient to reject intradermal tumors. Administering this adjuvant combination together with OVA as a tumor antigen induced T-cell responses that delayed tumor growth. However, administering a combination of anti-CD40 plus TLR3 and TLR7 ligands, together with antigen targeting to dendritic cells through TLR4, was sufficient to induce tumor rejection in 50% of mice. This response was associated with a greater activation of innate immunity and induction of high-avidity polyfunctional CD8+ T-cell responses, which each contributed to tumor rejection. This therapy activated T-cell responses not only against OVA, which conferred protection against a rechallenge with B16-OVA cells, but also activated T-cell responses against other melanoma-associated antigens. Our findings support the concept that multiple adjuvant combination and antigen targeting may be a useful immunotherapeutic strategy against poorly immunogenic tumors. Cancer Res; 71(9); 3214\u201324. \u00a92011 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-10-3259","type":"journal-article","created":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T15:09:23Z","timestamp":1300201763000},"page":"3214-3224","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors"],"prefix":"10.1158","volume":"71","author":[{"given":"Fernando","family":"Aranda","sequence":"first","affiliation":[{"name":"Authors' Affiliation: Division of Hepatology and Gene Therapy, University of Navarra, Center for Applied Medical Research (CIMA), Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Llopiz","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Division of Hepatology and Gene Therapy, University of Navarra, Center for Applied Medical Research (CIMA), Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"D\u00edaz-Vald\u00e9s","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Division of Hepatology and Gene Therapy, University of Navarra, Center for Applied Medical Research (CIMA), Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ignacio","family":"Riezu-Boj","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Division of Hepatology and Gene Therapy, University of Navarra, Center for Applied Medical Research (CIMA), Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaione","family":"Bezunartea","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Division of Hepatology and Gene Therapy, University of Navarra, Center for Applied Medical Research (CIMA), Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Ruiz","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Division of Hepatology and Gene Therapy, University of Navarra, Center for Applied Medical Research (CIMA), Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Division of Hepatology and Gene Therapy, University of Navarra, Center for Applied Medical Research (CIMA), Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maika","family":"Durantez","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Division of Hepatology and Gene Therapy, University of Navarra, Center for Applied Medical Research (CIMA), Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mansilla","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Division of Hepatology and Gene Therapy, University of Navarra, Center for Applied Medical Research (CIMA), Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Prieto","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Division of Hepatology and Gene Therapy, University of Navarra, Center for Applied Medical Research (CIMA), Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Lasarte","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Division of Hepatology and Gene Therapy, University of Navarra, Center for Applied Medical Research (CIMA), Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Borr\u00e1s-Cuesta","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Division of Hepatology and Gene Therapy, University of Navarra, Center for Applied Medical Research (CIMA), Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Sarobe","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Division of Hepatology and Gene Therapy, University of Navarra, Center for Applied Medical Research (CIMA), Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2011,4,29]]},"reference":[{"key":"2022061703534001600_bib1","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1056\/NEJMra072739","article-title":"Cancer immunology","volume":"358","author":"Finn","year":"2008","journal-title":"N Engl J Med"},{"key":"2022061703534001600_bib2","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1073\/pnas.86.14.5557","article-title":"Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia","volume":"86","author":"Smith","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061703534001600_bib3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.coi.2008.05.007","article-title":"Immunogenic cancer cell death: a key-lock paradigm","volume":"20","author":"Tesniere","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"2022061703534001600_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"2022061703534001600_bib5","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1158\/0008-5472.CAN-07-1652","article-title":"Toll-like receptor ligands energize peptide vaccines through multiple paths","volume":"67","author":"Celis","year":"2007","journal-title":"Cancer Res"},{"key":"2022061703534001600_bib6","doi-asserted-by":"crossref","first-page":"9012","DOI":"10.1158\/0008-5472.CAN-09-2019","article-title":"Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects","volume":"69","author":"Cho","year":"2009","journal-title":"Cancer Res"},{"key":"2022061703534001600_bib7","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1084\/jem.20031591","article-title":"Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN","volume":"199","author":"Ahonen","year":"2004","journal-title":"J Exp Med"},{"key":"2022061703534001600_bib8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ni1223","article-title":"Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells","volume":"6","author":"Napolitani","year":"2005","journal-title":"Nat Immunol"},{"key":"2022061703534001600_bib9","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2005-10-4015","article-title":"Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo","volume":"108","author":"Warger","year":"2006","journal-title":"Blood"},{"key":"2022061703534001600_bib10","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.bbrc.2007.01.090","article-title":"Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation","volume":"354","author":"Ouyang","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"2022061703534001600_bib11","doi-asserted-by":"crossref","first-page":"16260","DOI":"10.1073\/pnas.0805325105","article-title":"Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines","volume":"105","author":"Zhu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061703534001600_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00262-007-0346-8","article-title":"Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects","volume":"57","author":"Llopiz","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"2022061703534001600_bib13","first-page":"218","article-title":"Biological behavior of malignant melanoma cells correlated to their survival in vivo","volume":"35","author":"Fidler","year":"1975","journal-title":"Cancer Res"},{"key":"2022061703534001600_bib14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1084\/jem.184.2.465","article-title":"Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo","volume":"184","author":"Boczkowski","year":"1996","journal-title":"J Exp Med"},{"key":"2022061703534001600_bib15","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1084\/jem.186.7.1177","article-title":"Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors","volume":"186","author":"Ashley","year":"1997","journal-title":"J Exp Med"},{"key":"2022061703534001600_bib16","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.165.5.2651","article-title":"Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma","volume":"165","author":"Bellone","year":"2000","journal-title":"J Immunol"},{"key":"2022061703534001600_bib17","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.4049\/jimmunol.177.6.3564","article-title":"Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-beta gene","volume":"177","author":"Shibata","year":"2006","journal-title":"J Immunol"},{"key":"2022061703534001600_bib18","first-page":"2526","article-title":"Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challenge","volume":"63","author":"Krishnan","year":"2003","journal-title":"Cancer Res"},{"key":"2022061703534001600_bib19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00262-004-0655-0","article-title":"Beneficial therapeutic effects with different particulate structures of murine polyomavirus VP1-coat protein carrying self or non-self CD8 T cell epitopes against murine melanoma","volume":"54","author":"Brinkman","year":"2005","journal-title":"Cancer Immunol Immunother"},{"key":"2022061703534001600_bib20","doi-asserted-by":"crossref","first-page":"748","DOI":"10.4049\/jimmunol.178.2.748","article-title":"The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo","volume":"178","author":"Lasarte","year":"2007","journal-title":"J Immunol"},{"key":"2022061703534001600_bib21","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1002\/ijc.24656","article-title":"Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy","volume":"125","author":"Llopiz","year":"2009","journal-title":"Int J Cancer"},{"key":"2022061703534001600_bib22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1046\/j.1365-2567.2001.01213.x","article-title":"Tumours can act as adjuvants for humoral immunity","volume":"102","author":"Brown","year":"2001","journal-title":"Immunology"},{"key":"2022061703534001600_bib23","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1128\/JVI.02248-06","article-title":"Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection","volume":"81","author":"Larrea","year":"2007","journal-title":"J Virol"},{"key":"2022061703534001600_bib24","doi-asserted-by":"crossref","first-page":"7329","DOI":"10.1158\/0008-5472.CAN-09-0835","article-title":"In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells","volume":"69","author":"Scarlett","year":"2009","journal-title":"Cancer Res"},{"key":"2022061703534001600_bib25","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"2022061703534001600_bib26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway","volume":"3","author":"Hemmi","year":"2002","journal-title":"Nat Immunol"},{"key":"2022061703534001600_bib27","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1093\/emboj\/19.13.3304","article-title":"CD40 signaling in human dendritic cells is initiated within membrane rafts","volume":"19","author":"Vidalain","year":"2000","journal-title":"Embo J"},{"key":"2022061703534001600_bib28","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1087262","article-title":"Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway","volume":"301","author":"Yamamoto","year":"2003","journal-title":"Science"},{"key":"2022061703534001600_bib29","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1073\/pnas.93.9.4102","article-title":"Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy","volume":"93","author":"Alexander-Miller","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061703534001600_bib30","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1084\/jem.187.10.1647-b","article-title":"Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides","volume":"187","author":"Gallimore","year":"1998","journal-title":"J Exp Med"},{"key":"2022061703534001600_bib31","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.4049\/jimmunol.162.4.2227","article-title":"Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers","volume":"162","author":"Yee","year":"1999","journal-title":"J Immunol"},{"key":"2022061703534001600_bib32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4049\/jimmunol.162.2.989","article-title":"High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy","volume":"162","author":"Zeh","year":"1999","journal-title":"J Immunol"},{"key":"2022061703534001600_bib33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI39293","article-title":"Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice","volume":"120","author":"Zhu","year":"2010","journal-title":"J Clin Invest"},{"key":"2022061703534001600_bib34","doi-asserted-by":"crossref","first-page":"15154","DOI":"10.1073\/pnas.0406649101","article-title":"IL-15\/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells","volume":"101","author":"Oh","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061703534001600_bib35","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"2022061703534001600_bib36","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1128\/JVI.00228-07","article-title":"Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells","volume":"81","author":"Kannanganat","year":"2007","journal-title":"J Virol"},{"key":"2022061703534001600_bib37","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"key":"2022061703534001600_bib38","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1182\/blood-2003-04-1203","article-title":"Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy","volume":"103","author":"Harari","year":"2004","journal-title":"Blood"},{"key":"2022061703534001600_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/eji.200838824","article-title":"Tumor progression inhibits the induction of multifunctionality in adoptively transferred tumor-specific CD8+ T cells","volume":"39","author":"Imai","year":"2009","journal-title":"Eur J Immunol"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/71\/9\/3214\/2668697\/3214.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/71\/9\/3214\/2668697\/3214.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T15:11:49Z","timestamp":1685977909000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/71\/9\/3214\/575590\/Adjuvant-Combination-and-Antigen-Targeting-as-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,29]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2011,4,29]]},"published-print":{"date-parts":[[2011,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-10-3259","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22390682.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6503018.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6503018","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22390682","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,29]]}}}